Autologous cardiac stem cells (JRM-001) ( DrugBank: - )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 210 | Single Ventricle | 1 |
| 211 | Hypoplastic left heart syndrome | 1 |
210. Single Ventricle
Clinical trials : 51 / Drugs : 53 - (DrugBank : 22) / Drug target genes : 32 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02781922 (ClinicalTrials.gov) | June 2016 | 19/5/2016 | Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) | Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study | Hypoplastic Left Heart Syndrome;Single Ventricle | Genetic: Autologous cardiac stem cells (JRM-001) | Metcela Inc. | NULL | Recruiting | 0 Years | 6 Years | All | 40 | Phase 3 | Japan |
211. Hypoplastic left heart syndrome
Clinical trials : 22 / Drugs : 29 - (DrugBank : 9) / Drug target genes : 5 - Drug target pathways : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02781922 (ClinicalTrials.gov) | June 2016 | 19/5/2016 | Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) | Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study | Hypoplastic Left Heart Syndrome;Single Ventricle | Genetic: Autologous cardiac stem cells (JRM-001) | Metcela Inc. | NULL | Recruiting | 0 Years | 6 Years | All | 40 | Phase 3 | Japan |